Stocks
Wells Fargo Aims for 17-18% ROTCE: Key Drivers Behind Profitability Strategy
“`html Wells Fargo & Company (WFC) announced a new target for return on tangible common equity (ROTCE) of 17-18%, up from its previous aim ...
Q3 Earnings Forecast for Quantum Computing Stocks: IONQ, QBTS and Others
“`html As of Q3 2025, four major quantum computing companies—IonQ (IONQ), D-Wave Quantum (QBTS), Rigetti Computing (RGTI), and Quantum Computing Inc. (QUBT)—are set to ...
QXO Prepares to Unveil Q3 Earnings: What to Expect
“`html QXO Inc. is scheduled to report its third-quarter 2025 earnings on Nov. 6, 2025, after market close. The earnings estimate is 12 cents ...
Morgan Stanley’s Prospects: Will Increased Earnings Estimates Drive Growth?
“`html Morgan Stanley (MS) is experiencing a positive shift in its earnings outlook, with analysts raising earnings estimates significantly. For the current quarter, the ...
Teradyne (TER) Earnings Projections Improve: What’s Next for the Stock?
“`html Teradyne (TER) has seen a substantial increase in earnings estimates, with the current quarter expected to yield earnings of $1.18 per share, a ...
Bank of NT Butterfield & Son (NTB) Earnings Projections Improve: A Look at Future Growth Potential
“`html Bank of NT Butterfield & Son (NTB) has received a positive revision in its earnings estimates, now expected to earn $1.46 per share ...
Weatherford (WFRD) Earnings Forecasts Increase: Is This a Good Buying Opportunity?
“`html Weatherford International PLC (WFRD) has received a Zacks Rank #1 (Strong Buy) following a 15.69% increase in its earnings consensus estimate over the ...
WEC Energy Reports Strong Q3 Earnings and Increased Year-Over-Year Revenues
“`html WEC Energy Group reported third-quarter 2025 earnings of 83 cents per share, exceeding the Zacks Consensus Estimate of 79 cents by 5%. This ...
Medical Properties Reports Q2 NFFO Shortfall, Year-over-Year Revenue Growth
“`html Medical Properties Trust, Inc. (MPW) reported third-quarter 2025 normalized funds from operations (NFFO) of 13 cents per share, falling short of the Zacks ...
Strategies for BDTX Stock: Buy, Hold, or Sell Before Q3 Earnings Release?
“`html Black Diamond Therapeutics (BDTX) is set to report third-quarter results shortly, with investors keenly awaiting updates on its lead candidate, silevertinib. The Zacks ...
